Virtual Lupus Clinic 2024: Case 2
VLC02-EXP26
Lupus
Friday, February 2, 2024, 1:00 AM
Monday, February 1, 2027, 11:55 PM
CME, MOC, Participation
Advanced Practice Nurses, Dermatologists, Endocrinologists, Nephrologists, OB-GYNs, Primary Care Providers, Physician Assistants
Virtual Lupus Clinic
1.00
1.00

Activity Information

The Virtual Lupus Clinic is a four-part series providing case-based learning to help non-rheumatologists recognize, refer, and manage patients with lupus in conjunction with a rheumatologist.  Virtually examine four patients, each presenting with different symptoms, as described below. Decide which labs to order and build the differential diagnosis, taking into consideration lab results, patient exam, and patient and family history. Complete each case by deciding next steps for treating the patient, including appropriate referrals, if needed.

Case 2: A 27-year-old Hispanic male with a history of thrombocytopenia and recurrent pleurisy coming in with malar rash, pleural friction rub concerning for pleurisy, and hand synovitis.


Target Audience

Non-rheumatologist physicians, physician assistants, and nurse practitioners.


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify classic and atypical presentations of lupus, focusing on patient history, signs, symptoms, and physical examination findings
  • Identify and interpret lab studies typically utilized in a new patient workup sent when evaluating a new patient with lupus

  • Provide self-management and health maintenance education to patients


Registration Information

Registration is complimentary.


CME Information

Accreditation Statement                                                   

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement                                                   

The ACR designates this online activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to receive 1.00 MOC points for Case 2. If it is the one with all four cases bundled, then a participant can earn up to 4.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).


cme/moc


Faculty and Disclosures

ACR Disclosure Statement    

The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.

Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau

The faculty reported the following disclosures.


Faculty

Faculty Disclosures

  1. Petros Efthimiou, MD (Planner) – Springer7, Uptodate7, Pfizer5, Amgen5, Sanofi5, Kiniksa5
  2. M. Brad Nelson, MD, MPH (Planner) – None
  3. B. Anne Eberhard, MBBS (Planner) – None
  4. Parastoo Fazeli, MD (Planner) – None
  5. Schartess Culpepper Pace, MD (Planner) – None
  6. Nina Ramessar, MD (Planner) – GlaxoSmithKline8
  7. Kimberly DeQuattro, MD (Reviewer) – Kyverna Pharmaceuticals5, GlaxoSmithKline5
  8. Shivani Garg, MD (Reviewer) – None